Affimed NV (NASDAQ:AFMD) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET

Company Participants

Alexander Fudukidis - Head, IR

Adi Hoess - CEO

Angus Smith - CFO

Andreas Harstrick - Chief Medical Officer

Conference Call Participants

Daina Graybosch - SVB Securities

Maurice Raycroft - Jefferies

Li Watsek - Cantor Fitzgerald & Co.

Zhiqiang Shu - Berenberg

Yale Jen - Laidlaw & Company

Bijan Mekoba - Stifel, Nicolaus & Company

Operator

Good day, everyone, and welcome to the Affimed Second Quarter 2022 Financial Results and Corporate Update Conference Call. My name is Vanessa, and I will be your operator for today's call. [Operator Instructions]. As a reminder, this conference is being recorded.

I would now like to introduce your host for today's call, Mr. Alex Fudukidis, Head of Investor Relations at Affimed. Sir, you may begin.

Alexander Fudukidis

Thank you, Vanessa, and thank you all for joining us today for our call.

Before we begin, I'd like to remind everyone that we issued the relevant press release earlier today, which can be found on the Investor Relations section of our website.

On the call today, we have members of our management team, including Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Denise Mueller, our Chief Business Officer; and Angus Smith, our Chief Financial Officer. The team will be available for the Q&A session after the prepared remarks.

Before we start, I'd like to remind you that today's presentation contains projections and forward-looking statements regarding future events. These statements represent our beliefs and assumptions only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.

These forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in these statements due to various factors, including, but not limited to, those identified under the section entitled Risk Factors in our filings with the SEC and those identified under the section entitled Forward-Looking Statements in the press release that we issued today and filed with the SEC.

With that, I'll turn the call over to Adi. Adi?

Adi Hoess

Thank you, Alex. Good day, everyone, and thanks for joining our Second Quarter 2022 Financial Results and Operational Progress Update Call.